<VariationArchive VariationID="436730" VariationName="NM_001365088.1(SLC12A6):c.2436+1del" VariationType="Deletion" Accession="VCV000436730" Version="23" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-06-17" DateCreated="2015-03-24" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="429644" VariationID="436730">
      <GeneList>
        <Gene Symbol="SLC12A6" FullName="solute carrier family 12 member 6" GeneID="9990" HGNC_ID="HGNC:10914" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q14</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34229784" stop="34338057" display_start="34229784" display_stop="34338057" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_025791798.1" start="3625" stop="76798" display_start="3625" display_stop="76798" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34522196" stop="34630264" display_start="34522196" display_stop="34630264" Strand="-" />
          </Location>
          <OMIM>604878</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001365088.1(SLC12A6):c.2436+1del</Name>
      <CanonicalSPDI>NC_000015.10:34240659:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q14</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34240660" stop="34240660" display_start="34240660" display_stop="34240660" variantLength="1" positionVCF="34240659" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34532861" stop="34532861" display_start="34532861" display_stop="34532861" variantLength="1" positionVCF="34532860" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_270t2" sequenceAccession="LRG_270t2">
            <Expression>LRG_270t2:c.2436+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133647.1" sequenceAccession="NM_133647" sequenceVersion="1" change="c.2436delG">
            <Expression>NM_133647.1:c.2436delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133647.1" sequenceAccession="NM_133647" sequenceVersion="1" change="c.2436+1delG">
            <Expression>NM_133647.1:c.2436+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.34240661del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.34240661del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.34532862del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.34532862del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007951.1" sequenceAccession="NG_007951" sequenceVersion="1" change="g.102405del">
            <Expression>NG_007951.1:g.102405del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042495.2" sequenceAccession="NM_001042495" sequenceVersion="2" change="c.2259+1del">
            <Expression>NM_001042495.2:c.2259+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042494.2" sequenceAccession="NM_001042494" sequenceVersion="2" change="c.2259+1del">
            <Expression>NM_001042494.2:c.2259+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042496.2" sequenceAccession="NM_001042496" sequenceVersion="2" change="c.2409+1del">
            <Expression>NM_001042496.2:c.2409+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365088.1" sequenceAccession="NM_001365088" sequenceVersion="1" change="c.2436+1del" MANESelect="true">
            <Expression>NM_001365088.1:c.2436+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042497.2" sequenceAccession="NM_001042497" sequenceVersion="2" change="c.2391+1del">
            <Expression>NM_001042497.2:c.2391+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133647.2" sequenceAccession="NM_133647" sequenceVersion="2" change="c.2436+1del">
            <Expression>NM_133647.2:c.2436+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005135.2" sequenceAccession="NM_005135" sequenceVersion="2" change="c.2283+1del">
            <Expression>NM_005135.2:c.2283+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_270" sequenceAccession="LRG_270">
            <Expression>LRG_270:g.102405del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_270t1" sequenceAccession="LRG_270t1">
            <Expression>LRG_270t1:c.2283+1del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340395" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604878.0001" DB="OMIM" />
        <XRef Type="rs" ID="515726215" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2436+1del AND Agenesis of the corpus callosum with peripheral neuropathy" Accession="RCV000499636" Version="15">
        <ClassifiedConditionList TraitSetID="1484">
          <ClassifiedCondition DB="MedGen" ID="C0795950">Agenesis of the corpus callosum with peripheral neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2436+1del AND Charcot-Marie-Tooth disease" Accession="RCV000790219" Version="2">
        <ClassifiedConditionList TraitSetID="19856">
          <ClassifiedCondition DB="MedGen" ID="C0007959">Charcot-Marie-Tooth disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2436+1del AND not provided" Accession="RCV001357809" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2015-03-24" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12368912</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12838516</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16606917</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17893295</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21628467</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301546</ID>
          <ID Source="BookShelf">NBK1372</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1484" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Agenesis of the corpus callosum with peripheral neuropathy</ElementValue>
                <XRef ID="MONDO:0000902" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charlevoix disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Corpus callosum agenesis neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyneuropathy, sensorimotor, with or without agenesis of the corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with peripheral neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with polyneuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMSN/ACC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andermann syndrome</ElementValue>
                <XRef ID="Andermann+Syndrome/429" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACCPN</ElementValue>
                <XRef Type="MIM" ID="218000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1537" />
                <XRef ID="1537" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264022" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553541" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552164" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), a neurodevelopmental and neurodegenerative disorder, is characterized by severe progressive sensorimotor neuropathy with resulting hypotonia, areflexia, and amyotrophy, and by variable degrees of dysgenesis of the corpus callosum. Mild-to-severe intellectual disability and "psychotic episodes" during adolescence are observed. Sensory modalities are moderately to severely affected beginning in infancy. The average age of onset of walking is 3.8 years; the average age of loss of walking is 13.8 years; the average age of death is 33 years.</Attribute>
                <XRef ID="NBK1372" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301546</ID>
                <ID Source="BookShelf">NBK1372</ID>
              </Citation>
              <XRef ID="1496" DB="Orphanet" />
              <XRef ID="C0795950" DB="MedGen" />
              <XRef ID="MONDO:0000902" DB="MONDO" />
              <XRef Type="MIM" ID="218000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19856" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="13540" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease</ElementValue>
                <XRef ID="Charcot-Marie-Tooth+Disease/1276" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015626" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS118220" DB="OMIM" />
                <XRef ID="50548001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth Neuropathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HMSN</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6034" />
                <XRef ID="6034" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="MDA Consensus document - CMT testing, 2011">
                <ID Source="pmc">3058597</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301532</ID>
                <ID Source="BookShelf">NBK1358</ID>
              </Citation>
              <XRef ID="166" DB="Orphanet" />
              <XRef ID="C0007959" DB="MedGen" />
              <XRef ID="MONDO:0015626" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS118220" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1153514" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_133647.1(SLC12A6):c.2436+1del|Agenesis of the corpus callosum with peripheral neuropathy" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000597060" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.1:c.2436+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Agenesis of the corpus callosum with peripheral neuropathy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="288255" SubmissionDate="2014-06-13" DateLastUpdated="2022-10-01" DateCreated="2014-06-23">
        <ClinVarSubmissionID localKey="NM_133647.1:c.2436delG|OMIM:218000" />
        <ClinVarAccession Accession="SCV000166716" DateUpdated="2022-10-01" DateCreated="2014-06-23" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1372</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>French-Canadian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_598408.1:p.Thr813ProfsTer2</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.1:c.2436delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0795950" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>epb42-spherocytosis_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25832" SubmissionDate="2016-09-15" DateLastUpdated="2024-01-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604878.0001_AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" title="SLC12A6, 1-BP DEL, 2436G_AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" />
        <ClinVarAccession Accession="SCV000025832" DateUpdated="2024-01-26" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 20 French Canadians with agenesis of the corpus callosum with peripheral neuropathy (ACCPN; 218000) from the Charlevoix and Saguenay-Lac-Saint-Jean regions of the province of Quebec in Canada, Howard et al. (2002) found homozygosity for a guanine deletion in exon 18 at nucleotide 2436 (c.2436delG) of the KCC3A open reading frame. The deletion converted GT at the splice donor site of exon 18 to TA, suggesting an effect on RNA splicing. Furthermore, this splice site mutation was predicted to cause a premature stop codon at amino acid 813, removing the last 338 amino acids from the KCC3 protein (2436delG, Thr813fsTer813). Functional expression studies in Xenopus oocytes showed that the truncated mutant protein was appropriately glycosylated and expressed at the cellular membrane, but was nonfunctional.</Attribute>
              <Citation>
                <ID Source="PubMed">12368912</ID>
              </Citation>
              <XRef DB="OMIM" ID="218000" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 2436del mutation in the SLC12A6 gene that was found in compound heterozygous state in a patient with ACCPN by Howard et al. (2002), see 604878.0002.</Attribute>
              <Citation>
                <ID Source="PubMed">12368912</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Variant Function</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Salin-Cantegrel et al. (2011) found that the mutant T813X protein had abnormal intracellular localization around the nucleus in brain tissue from a patient with the mutation. The mutant protein was not found in swollen axons. The findings suggested a transit defect of the mutant protein.</Attribute>
              <Citation>
                <ID Source="PubMed">21628467</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <Name>SLC12A6, 1-BP DEL, 2436G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2436G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604878.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794830" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_133647.1:c.2436+1delG|MedGen:C0795950" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000918210" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Comment>Variant summary: SLC12A6 c.2436+1delG is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes a 5' splicing donor site, while three predict the variant weakens a 5' donor site. These predictions are supported by a study that found a cryptic splice site is preferentially used in patient cells and the resulting protein product is reduced in size and does not function in chloride dependent uptake of 86Rb+ compared to controls, although it is properly localized and glycosylated (Howard_2002). The variant allele was found at a frequency of 5.4e-05 in 277348 control chromosomes. This frequency is not higher than expected for a pathogenic variant in SLC12A6 causing Andermann Syndrome (5.4e-05 vs 0.025), allowing no conclusion about variant significance. c.2436+1delG has been reported in the literature in numerous homozygous French Canadian individuals affected with Andermann Syndrome. These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.1:c.2436+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Andermann syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0795950" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1819115" SubmissionDate="2019-07-10" DateLastUpdated="2019-07-27" DateCreated="2019-07-27">
        <ClinVarSubmissionID localKey="NM_133647.1:c.2436+1delG|Orphanet:ORPHA:166" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000929611" DateUpdated="2019-07-27" DateCreated="2019-07-27" Type="SCV" Version="1" SubmitterName="Inherited Neuropathy Consortium" OrgID="506440" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.1:c.2436+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA166" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5939204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354689" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="12|OMIM:218000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194234" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000677914" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000677914 was merged into SCV001194234 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Comment>NM_133647.1(SLC12A6):c.2436+1delG(aka T813fs*813) is classified as pathogenic in the context of Andermann syndrome. Sources cited for classification include the following: PMID 12368912. Classification of NM_133647.1(SLC12A6):c.2436+1delG(aka T813fs*813) is based on the following criteria: The variant is located at a canonical splice site, is expected to disrupt gene function and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="A" referenceAllele="AC" start="34532860" stop="34532861" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3054554" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr15:34532859-34532861:30e641edc63ecdd5d97378f703e20eb1" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001553393" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="A" referenceAllele="AC" start="34532860" stop="34532861" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4027666" SubmissionDate="2022-01-10" DateLastUpdated="2022-01-12" DateCreated="2022-01-12">
        <ClinVarSubmissionID localKey="NM_001365088.1:c.2436+1del|OMIM:218000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002055412" DateUpdated="2022-01-12" DateCreated="2022-01-12" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001365088.1:c.2436+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918493</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4113442" SubmissionDate="2022-03-09" DateLastUpdated="2023-03-04" DateCreated="2022-03-12">
        <ClinVarSubmissionID localKey="GDXSV:222305" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002102613" DateUpdated="2023-03-04" DateCreated="2022-03-12" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect resulting in nonfunctional protein (Howard et al., 2002); Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20301546, 12368912)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="15" alternateAllele="-" referenceAllele="C" start="34532861" stop="34532861" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:730102</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_93_20220309054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111295" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4921152|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585649" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16606917</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12838516</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17893295</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (Splice site) in the SLC12A6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A6 are known to be pathogenic (PMID: 12368912, 16606917). This variant is present in population databases (rs752155285, gnomAD 0.009%). This premature translational stop signal has been observed in individuals with agenesis of the corpus callosum with peripheral neuropathy (PMID: 12368912, 12838516, 17893295). It is commonly reported in individuals of French Canadian ancestry (PMID: 12368912). This variant is also known as c.2436+1del. ClinVar contains an entry for this variant (Variation ID: 436730). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.34532861del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855510" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_133647.2:c.2436+1del|OMIM:218000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201150" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.2:c.2436+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1153514" TraitType="Disease" MappingType="Name" MappingValue="Agenesis of the corpus callosum with peripheral neuropathy" MappingRef="Preferred">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4113442" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354689" TraitType="Disease" MappingType="XRef" MappingValue="218000" MappingRef="OMIM">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3111295" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="288255" TraitType="Disease" MappingType="XRef" MappingValue="C0795950" MappingRef="MedGen">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1819115" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA166" MappingRef="Orphanet">
        <MedGen CUI="C0007959" Name="Charcot-Marie-Tooth disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3054554" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7855510" TraitType="Disease" MappingType="XRef" MappingValue="218000" MappingRef="OMIM">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25832" TraitType="Disease" MappingType="Name" MappingValue="AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" MappingRef="Preferred">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4027666" TraitType="Disease" MappingType="XRef" MappingValue="218000" MappingRef="OMIM">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1794830" TraitType="Disease" MappingType="Name" MappingValue="Andermann syndrome" MappingRef="Preferred">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

